Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs Old Dominion Freight Line Inc (ODFL) Price & Performance

Amgen, Inc.
Old Dominion Freight Line Inc

Price performance

Price movement over the last 24 hours

Key statistics

Amgen, Inc. vs Old Dominion Freight Line Inc — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Old Dominion Freight Line Inc trades at $227.63 (market cap $47.34B). The key difference: Amgen, Inc. is far larger — about 4.1× Old Dominion Freight Line Inc's market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.

AMGNODFL
Market Cap
$196.12B$47.34B
Sector
HealthIndustrials
52-Week High
$388.16$248.73
52-Week Low
$271.18$126.29
Enterprise Value
$241.41B$47.09B
Dividend Yield
2.77%0.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amgen, Inc.

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

Old Dominion Freight Line Inc

ODFL trades at $227.63, up 0.79% today, near its consensus price target of $231.29. The stock shows bullish technical signals with strong moving averages, though RSI indicates mild overbought conditions. Fundamentally, ODFL maintains high profitability with an 18.46% net margin and 23.33% ROE, but valuation ratios like P/E of 47.52 are elevated. Recent earnings beats and a solid balance sheet with minimal debt support its quality, while news highlights mixed sentiment amid freight market recovery and competitive pressures from Amazon's LTL expansion.

Outlook: ODFL offers a high-quality play on freight recovery with robust fundamentals, but rich valuation and near-term headwinds warrant caution. Upside depends on Q2 2026 earnings meeting the $1.51 EPS estimate. Risks include economic sensitivity and rising competition. Analyst consensus is mixed with 33% buy ratings, suggesting patience for better entry points may be prudent.

Returns comparison

Trailing returns across standard periods

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About Old Dominion Freight Line Inc

Old Dominion Freight Line is the fourth-largest less-than-truckload carrier in the United States, with more than 240 service centers and 9,200-plus tractors. OD is by far one of the most disciplined and efficient providers in the trucking industry, and its profitability and capital returns stand head and shoulders above its peers. Strategic initiatives revolve around increasing network density through market share gains and maintaining industry-leading service via consistent infrastructure investment.

Read more on ODFL